{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:20:33Z","timestamp":1787242833716,"version":"build-2736575974"},"reference-count":29,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Real-world evidence (RWE) has been used to improve quality of care, accelerate innovation, and evaluate emerging therapies for drugs, devices, and biologics. The Coordinated Registry Network (CRN), aggregating and linking highly curated patient data, has emerged as a model for RWE generation that has guided the development of the American Society of Hematology Research Collaborative (ASH RC) Data Hub. With the aim of bolstering research, enhancing clinical care, and expediting evidence generation using RWE, the ASH RC and the Innovative Genomics Institute launched a joint initiative, \u201cAccelerating Innovations for Sickle Cell Disease (SCD) with Real-World Evidence,\u201d to evaluate and make recommendations to the Data Hub. An expert panel used a \"maturity model\" to evaluate the following: (1) Data Hub standardization of RWE guidelines to ensure successful monitoring of new therapies' safety and effectiveness; and (2) the Data Hub\u2019s engagement with patients (including collection of data on patient experience) and collaboration among partners, including regulators, industry, and clinicians. The Data Hub gathers patient-level data from electronic health records, with plans to incorporate data from individuals receiving gene therapy. The program is currently curating and aggregating data on \u223c27\u2009000 individuals with SCD cared for across 22 hospitals in the United States. The SCD Data Hub program includes a total of 56 centers, some of which are not yet contributing data, which will increase the total cohort to \u223c50\u2009000 patients. The unique organizational structure of the CRN model facilitates acceleration of innovation through collaborative relationships between multiple clinical sites and partners with various evidentiary needs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024015532","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T17:40:27Z","timestamp":1754674827000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Accelerating novel therapies for sickle cell disease with RWE: ASH RC Data Hub as a strategically coordinated registry network"],"prefix":"10.1182","volume":"10","author":[{"given":"William A.","family":"Wood","sequence":"first","affiliation":[{"name":"1Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4987-3753","authenticated-orcid":false,"given":"Osman N.","family":"Yogurtcu","sequence":"additional","affiliation":[{"name":"2US Food and Drug Administration, Silver Spring, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Semmel","sequence":"additional","affiliation":[{"name":"3ASH Research Collaborative, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Hewitt","sequence":"additional","affiliation":[{"name":"3ASH Research Collaborative, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna S.","family":"Neuberg","sequence":"additional","affiliation":[{"name":"4Department of Data Science, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5690-7267","authenticated-orcid":false,"given":"Lea B.","family":"Witkowsky","sequence":"additional","affiliation":[{"name":"5Kavli Center for Ethics, Science, and the Public, University of California, Berkeley, Berkeley, CA"},{"name":"6Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1289-4254","authenticated-orcid":false,"given":"Ken","family":"Taymor","sequence":"additional","affiliation":[{"name":"6Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9049-518X","authenticated-orcid":false,"given":"Santiago J.","family":"Molina","sequence":"additional","affiliation":[{"name":"7Department of Sociology at Northwestern University, Evanston, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4439-7321","authenticated-orcid":false,"given":"Jane S.","family":"Hankins","sequence":"additional","affiliation":[{"name":"8Department of Global Pediatric Medicine, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4961-8103","authenticated-orcid":false,"given":"Alexis A.","family":"Thompson","sequence":"additional","affiliation":[{"name":"9Division of Hematology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Pappas","sequence":"additional","affiliation":[{"name":"2US Food and Drug Administration, Silver Spring, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"2026011308513196500_bib1","unstructured":"US Food and Drug Administration\n          . Real-world evidence. Accessed 1 May 2023. https:\/\/www.fda.gov\/science-research\/science-and-research-special-topics\/real-world-evidence."},{"key":"2026011308513196500_bib2","unstructured":"US Food and Drug Administration\n          . Framework for FDA's real-world evidence program. Accessed 27 April 2023. https:\/\/www.fda.gov\/media\/120060\/download."},{"key":"2026011308513196500_bib3","unstructured":"US Congress\n          . 21st century cures act, Sec. 3022. Accessed 14 August 2025. https:\/\/www.congress.gov\/114\/plaws\/publ255\/PLAW-114publ255.pdf."},{"issue":"6","key":"2026011308513196500_bib4","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s43441-024-00680-z","article-title":"A comprehensive framework for evaluating the value created by real-world evidence for diverse stakeholders: the case for coordinated registry networks","volume":"58","author":"Gressler","year":"2024","journal-title":"Ther Innov Regul Sci"},{"key":"2026011308513196500_bib5","unstructured":"US Food and Drug Administration\n          . Recommendations for a national medical device evaluation system: strategically coordinated registry networks to bridge clinical care and research: a report from the medical device registry task force & the medical devices epidemiology network. 2015. Accessed 18 August 2023. https:\/\/www.federalregister.gov\/documents\/2015\/08\/25\/2015-20948\/medical-device-epidemiology-network-registry-task-force-report-availability-web-site-location-and."},{"issue":"16","key":"2026011308513196500_bib6","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1001\/jama.2015.11036","article-title":"Bridging unmet medical device ecosystem needs with strategically coordinated registries networks","volume":"314","author":"Krucoff","year":"2015","journal-title":"JAMA"},{"issue":"suppl 1","key":"2026011308513196500_bib7","doi-asserted-by":"crossref","first-page":"e000123","DOI":"10.1136\/bmjsit-2021-000123","article-title":"Maturity framework and select approaches for developing coordinated registry networks (CRNs): medical device epidemiology network (MDEpiNet) supplement","volume":"4","author":"Sedrakyan","year":"2022","journal-title":"BMJ Surg Interv Health Technol"},{"key":"2026011308513196500_bib8","unstructured":"ASH Research Collaborative\n          . Real-world evidence initiative. Accessed 14 August 2025. https:\/\/www.ashresearchcollaborative.org\/data-hub\/programs\/real-world-evidence-initiative\/."},{"issue":"23","key":"2026011308513196500_bib9","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1182\/bloodadvances.2021005902","article-title":"ASH research collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematology","volume":"5","author":"Wood","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"2026011308513196500_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s43856-022-00148-x","article-title":"Recommendations for achieving interoperable and shareable medical data in the USA","volume":"2","author":"Szarfman","year":"2022","journal-title":"Commun Med"},{"issue":"suppl 1","key":"2026011308513196500_bib11","doi-asserted-by":"crossref","first-page":"e000123","DOI":"10.1136\/bmjsit-2021-000123","article-title":"Advancing the real-world evidence for medical devices through coordinated registry networks","volume":"4","author":"Sedrakyan","year":"2022","journal-title":"BMJ Surg Interv Health Technol"},{"key":"2026011308513196500_bib12","unstructured":"ASH Research Collaborative Genomic Therapies Work Group\n          . Accelerating innovations for sickle cell disease with real-world evidence. Accessed 14 August 2025. https:\/\/hematology.my.salesforce.com\/sfc\/p\/6A000000uIj9\/a\/3u000000MgQD\/bE2PbOhI4fwWCHK2O6v4YFxloXOCL.M6IN3WgVcAeL4."},{"key":"2026011308513196500_bib13","unstructured":"ASH Research Collaborative Coordinated Registry Network Work Group\n          . Accelerating innovations for sickle cell disease with real-world evidence. Accessed 14 August 2025. https:\/\/hematology.my.salesforce.com\/sfc\/p\/6A000000uIj9\/a\/3u000000MgQI\/69J.PGurkrmqVUS1SS1r46mK_5qz7g.bCCIxl1qGHOM."},{"key":"2026011308513196500_bib14","unstructured":"MDEpiNet\n          . Coordinated registry networks. Accessed 14 August 2025. https:\/\/www.mdepinet.net\/coordinated-registry-networks."},{"issue":"suppl 1","key":"2026011308513196500_bib15","doi-asserted-by":"crossref","first-page":"e000113","DOI":"10.1136\/bmjsit-2021-000113","article-title":"Developing the foundation for assessment of devices used for acute ischemic stroke interventions (DAISI) using a coordinated registry network","volume":"4","author":"LeRoy","year":"2022","journal-title":"BMJ Surg Interv Health Technol"},{"key":"2026011308513196500_bib16","unstructured":"Quantum Leap Healthcare Collaborative\n          . Automated data capture from health record systems. Accessed 7 September 2024. https:\/\/www.quantumleaphealth.org\/partnerships\/onesource\/."},{"key":"2026011308513196500_bib17","unstructured":"OpenClinica\n          . EHR to EDC eSource at its best. Accessed 14 August 2025. https:\/\/www.openclinica.com\/unite-ehr-esource-2\/."},{"key":"2026011308513196500_bib18","unstructured":"US Food and Drug Administration\n          . Source data capture from electronic health records (EHRs): using standardized clinical research data (OneSource phase I). Accessed 14 August 2025. https:\/\/www.fda.gov\/science-research\/advancing-regulatory-science\/source-data-capture-electronic-health-records-ehrs-using-standardized-clinical-research-data."},{"issue":"6","key":"2026011308513196500_bib19","doi-asserted-by":"crossref","first-page":"e006292","DOI":"10.1161\/CIRCOUTCOMES.119.006292","article-title":"Computable phenotype implementation for a national, multicenter pragmatic clinical trial: lessons learned from ADAPTABLE","volume":"13","author":"Ahmad","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026011308513196500_bib20","unstructured":"US Food Drug and Administration\n          . Real-world data: assessing registries to support regulatory decision-making for drug and biological products. https:\/\/www.fda.gov\/media\/154449\/download."},{"issue":"1","key":"2026011308513196500_bib21","doi-asserted-by":"crossref","first-page":"e000003","DOI":"10.1136\/bmjsit-2019-000003","article-title":"Determining value of coordinated registry networks (CRNs): a case of transcatheter valve therapies","volume":"1","author":"Pappas","year":"2019","journal-title":"BMJ Surg Interv Health Technol"},{"key":"2026011308513196500_bib22","unstructured":"US Food Drug and Administration\n          . Real-world data: assessing registries to support regulatory decision-making for drug and biological products. https:\/\/www.fda.gov\/media\/152503\/download."},{"key":"2026011308513196500_bib23","unstructured":"Manatt Phelps & Phillips LLP\n          . Realizing the promise of all-payer claims databases. Accessed 14 August 2025. https:\/\/www.manatt.com\/insights\/newsletters\/health-highlights\/realizing-the-promise-of-all-payer-claims-database."},{"issue":"14","key":"2026011308513196500_bib24","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/bloodadvances.2021004634","article-title":"A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease","volume":"5","author":"Rampersaud","year":"2021","journal-title":"Blood Adv"},{"issue":"10","key":"2026011308513196500_bib25","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"2026011308513196500_bib26","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/bloodadvances.2018017541","article-title":"Identification of patients with hemoglobin SS\/S\u03b20 thalassemia disease and pain crises within electronic health records","volume":"2","author":"Singh","year":"2018","journal-title":"Blood Adv"},{"key":"2026011308513196500_bib27","article-title":"Building real-world evidence infrastructure to improve health and healthcare in the United States: part I \u2013 coordinated registry networks and systemic coordinated inter-organizational networks","author":"Yogurtcu","year":"2025","journal-title":"Int J Transl Med Res Public Health"},{"key":"2026011308513196500_bib28","article-title":"Building real-world evidence infrastructure to improve health and healthcare in the United States: part II \u2013 how coordinated registry networks operate like a systemic coordinated inter-organizational network","author":"Yogurtcu","year":"2025","journal-title":"Int J Transl Med Res Public Health"},{"key":"2026011308513196500_bib29","article-title":"Building real-world evidence infrastructure to improve health and healthcare in the United States: part III \u2013 questions for translational science and action theory","author":"Yogurtcu","year":"2025","journal-title":"Int J Transl Med Res Public Health"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/1\/39\/2478160\/blooda_adv-2024-015532-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/1\/39\/2478160\/blooda_adv-2024-015532-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:51:42Z","timestamp":1768312302000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/1\/39\/546529\/Accelerating-novel-therapies-for-sickle-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024015532","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1,13]]},"published":{"date-parts":[[2025,12,29]]}}}